Your Solutions in China

Your Solutions in China

Enhance Drug Accessibility of World

Enhance Drug Accessibility of World

COMPANY
Empower Pharmaceutical industry by synthesis and sourcing
FondChem was founded in 2016 by a group of chemistry enthusiasts who have similar pursuits. We hope to link the China pharmaceutical industry with other countries around the world through chemistry. Introduce China's comprehensive manufacturing and innovation capabilities to other global markets, accelerate drug research and production, and enhance drug accessibility. After years of development, our business covers sourcing and exporting services of Intermediates and Active Pharmaceutical Ingredients (APIs) for overseas customers, as well as Contracted Development and Manufacturing (CDMO) services of small molecule products. Professional team, rich experience honour FondChem as a valuable solution for pharmaceutical industry.
PRODUCTS

PRODUCTS

API

We provide cGMP compliant products with DMF/ASMF/MF documents for regulatory registration. And our marketing team provides full value information services such as API product global consumption, market competition, patent analysis, etc. to support customers in making optimal decision.

Intermediate

We provide starting materials, KSM according to GMP or ISO , and a complete set of CMC documents support.

CDMO/CMO

CDMO services for small molecule products is provided, including APIs, building blocks, from product trial development to GMP commercial production.

For generic API, We provide innovative polymorph form/salt form development, breaking through the limitations of original drug patents, innovating synthesis process routes, and helping customers launch to market in advance.

For building blocks, We provide customized development and production for small molecule raw materials that are difficult to find in the existing market. Special reactions including hydrogenation,low-temperature reactions, continuous flow chemistry,enzyme catalysis, etc.

CDMO
CDMO
01
02

NEW MOLECULES

With the continuous emergence of new technologies such as Artificial Intelligence, RNA, and CGT, more and more innovative therapies bring new hope to patients. And China has also contributed an indispensable force in this new global trend. We are committed to establishing ourselves in China, connecting with the world, and recommending Chinese innovative capabilities to the global market. At present, we provide various small molecule raw materials such as ADC payload, linker, Phosphoramidite, nucleotide, Peptide, Protac molecules, etc. for the fields of ADC, RNAi, mRNA, Protac, RDC.

LIVE

Sudden container crunch sends ocean freight rates soaring…
27-06-2024
Sudden container crunch sends ocean freight rates soaring…
In Focus : Sodium Perchlorate Monohydrate
28-06-2024
In Focus : Sodium Perchlorate Monohydrate
Chemspec Europe – The Fine & Speciality Chemicals Exhibition
27-06-2024
Chemspec Europe – The Fine & Speciality Chemicals Exhibition